Nerve growth factor inhibition with tanezumab influences weight-bearing and subsequent cartilage damage in the rat medial meniscal tear model
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nerve growth factor inhibition with tanezumab influences weight-bearing and subsequent cartilage damage in the rat medial meniscal tear model
Authors
Keywords
-
Journal
ANNALS OF THE RHEUMATIC DISEASES
Volume 76, Issue 1, Pages 295-302
Publisher
BMJ
Online
2016-07-06
DOI
10.1136/annrheumdis-2015-208913
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serious joint-related adverse events in randomized controlled trials of anti-nerve growth factor monoclonal antibodies
- (2015) M.C. Hochberg OSTEOARTHRITIS AND CARTILAGE
- Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain
- (2014) Thomas J Schnitzer et al. ANNALS OF THE RHEUMATIC DISEASES
- Augmented pain behavioural responses to intra-articular injection of nerve growth factor in two animal models of osteoarthritis
- (2013) Sadaf Ashraf et al. ANNALS OF THE RHEUMATIC DISEASES
- Tanezumab Reduces Osteoarthritic Hip Pain: Results of a Randomized, Double-Blind, Placebo-Controlled Phase III Trial
- (2013) Mark T. Brown et al. ARTHRITIS AND RHEUMATISM
- A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee
- (2013) Egilius L.H. Spierings et al. PAIN
- Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain
- (2013) Alan J. Kivitz et al. PAIN
- Tanezumab Reduces Osteoarthritic Knee Pain: Results of a Randomized, Double-Blind, Placebo-Controlled Phase III Trial
- (2012) Mark T. Brown et al. JOURNAL OF PAIN
- Antagonism of Nerve Growth Factor-TrkA Signaling and the Relief of Pain
- (2011) Patrick W. Mantyh et al. ANESTHESIOLOGY
- Efficacy and safety of intravenous tanezumab in osteoarthritis hip and knee pain: comparison to placebo and naproxen in two phase III studies (NCT00830063 & NCT00863304)
- (2011) E. Ekman et al. JOURNAL OF PAIN
- Proof of Concept Trial of Tanezumab for the Treatment of Symptoms Associated With Interstitial Cystitis
- (2011) R.J. Evans et al. JOURNAL OF UROLOGY
- Efficacy and safety of tanezumab in the treatment of chronic low back pain
- (2011) Nathaniel Katz et al. PAIN
- Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee
- (2010) Nancy E. Lane et al. NEW ENGLAND JOURNAL OF MEDICINE
- The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the rat
- (2010) N. Gerwin et al. OSTEOARTHRITIS AND CARTILAGE
- A multiple-dose toxicity study of tanezumab in cynomolgus monkeys
- (2010) Mark Zorbas et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis
- (2010) D. A. Walsh et al. RHEUMATOLOGY
- The nerve of osteoarthritis pain
- (2010) Jacqueline R. Hochman et al. ARTHRITIS CARE & RESEARCH
- Targeting Nerve Growth Factor in Pain
- (2008) Judy J Watson et al. BIODRUGS
- Probing the binding mechanism and affinity of tanezumab, a recombinant humanized anti-NGF monoclonal antibody, using a repertoire of biosensors
- (2008) Yasmina Noubia Abdiche et al. PROTEIN SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation